Do tiny cancer cells in lymph nodes matter? new study aims to find out
NCT ID NCT06689956
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is for people with a low-risk type of uterine cancer (endometrial cancer). Researchers want to see if finding very small groups of cancer cells (called isolated tumor cells) in the first lymph nodes near the tumor changes the chance of the cancer coming back. About 212 participants will be followed over time, but no new treatment is given—this is just observation to learn more.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict recurrence risk in low-risk endometrial cancer, potentially guiding future treatment decisions.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to any change in care, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIGO GRADE 1 ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
AC Camargo Cancer Center
RECRUITINGSão Paulo, Brazil
-
European Institute of Oncology
RECRUITINGMilan, MI, 20141, Italy
-
Fondazione IRCCS Istituto Nazionale Tumori
RECRUITINGMilan, MI, 20133, Italy
-
Hopital Maisonneuve Rosemont
RECRUITINGMontreal, Quebec, H1T 2M4, Canada
-
Hospital Materno Infantil Las Palmas
RECRUITINGLas Palmas, 35016, Spain
-
Hospital Universitario La Paz
RECRUITINGMadrid, 28029, Spain
-
Houston Methodist Hospital
RECRUITINGHouston, Texas, 77030, United States
-
IRCCS Fondazione San Gerardo dei Tintori
NOT_YET_RECRUITINGMonza, MB, 20900, Italy
-
Institut Universitaire du Cancer Toulouse Oncopole
NOT_YET_RECRUITINGToulouse, 31100, France
-
Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale
NOT_YET_RECRUITINGNaples, 80131, Italy
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Email: •••••@•••••
-
Medical University of Vienna
RECRUITINGVienna, Austria
-
Meir Medical Center, Faculty of Medicine - Tel-Aviv University
NOT_YET_RECRUITINGKefar Sava, Israel
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
-
Ospedale Michele e Pietro Ferrero
NOT_YET_RECRUITINGVerduno, CN, 12060, Italy
-
Ospedale Regionale di Lugano, Civico
RECRUITINGLugano, 6900, Switzerland
-
Policlinico Universitario Fondazione Agostino Gemelli
RECRUITINGRoma, RM, 00168, Italy
-
Sunnybrook Health Sciences, University of Toronto
RECRUITINGToronto, Ontario, M4N 3M5, Canada
-
University Hospital Essen
NOT_YET_RECRUITINGEssen, 45147, Germany
-
University of Udine
NOT_YET_RECRUITINGUdine, UD, 33100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New study aims to predict cancer return in Low-Risk patients
- Could a hormonal IUD replace surgery for some uterine cancers?
- Weight-loss shot plus IUD may help reverse womb cancer without surgery
- Remote strength training aims to boost endometrial cancer survivorship in rural areas
- New drug combo aims to outsmart Chemo-Resistant ovarian cancer
- New combo therapy shows promise for Tough-to-Treat endometrial cancer